Organization
RTI Health Solutions
8 abstracts
Abstract
Overall survival with palbociclib (PAL) plus an aromatase inhibitor (AI) versus AI alone in older patients (pts) with de novo, HR+/HER2− metastatic breast cancer: A SEER-Medicare analysis.Org: Pfizer AB, Pfizer Inc., RTI Health Solutions, University of Pittsburgh, University of California Irvine,
Abstract
Preferences among patients with triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM) in the era of B-cell maturation antigen (BCMA)-directed T-cell–engaging therapies.Org: Mayo Clinic Florida, Regeneron Pharmaceuticals, Inc., RTI Health Solutions,
Abstract
Health-related quality of life (HRQOL) in patients (pts) with advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC) or esophageal adenocarcinoma (EAC): 36-month results of nivolumab plus chemotherapy (N+C) versus (C) from CheckMate 649.Org: Princess Margaret Cancer Centre, University Health Network, Klinika Onkologii i Radioterapii, Narodowy Instytut Onkologii, Bristol Myers Squibb,
Abstract
Upfront vs deferred monoclonal antibodies in metastatic colorectal cancer: A target trial emulation using the GEMCAD 14-01 prospective cohort.Org: Hospital Clínic Barcelona, Antwerp University Hospital, Hospital Univ. Miguel Servet, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, Complejo Hospitalario Universitario Ourense,
Abstract
Side effects and impacts of extended adjuvant endocrine therapy: A qualitative study among women with HR+/HER2- breast cancer.Org: RTI Health Solutions, Sanofi, University of North Carolina School of Medicine,
Abstract
Treatment patterns of triple-class refractory (TCR) multiple myeloma (MM) across the United States (US), Canada, and western Europe: A real-world observational chart review study.Org: RTI Health Solutions, Pfizer Inc., London, United Kingdom,
Abstract
Real-world assessment of treatment effectiveness in patients with advanced non-small cell lung cancer (aNSCLC) with MET exon 14 skipping (METex14).Org: University of Iowa Hospitals & Clinics, Carver College of Medicine - University of Iowa, Iowa City, IA, RTI Health Solutions, Research Triangle Park, NC,
Abstract
ASSESSING METHOTREXATE COMPLIANCE IN RHEUMATOID ARTHRITIS Org: RTI Health Solutions, Genentech, Research Triangle Park, NC, NC Medical Research, Inc.,